Journal for ImmunoTherapy of Cancer (Nov 2021)

775 An induced pluripotent stem cell (iPSC) vaccine decreases tumor growth and improves survival in a therapeutic mouse model of colon cancer

Matthias Hundt,
Peter Bove,
Ivan Hernandez,
Michelle Li,
Pratima Kundu,
Nigel Kooreman,
Stephen Wolpe,
Lynne Bui,
Carlos Obejero-Paz

Affiliations

Matthias Hundt: Khloris Biosciences, Mountain View, CA, United States
Peter Bove: Khloris Biosciences, Mountain View, CA, United States
Ivan Hernandez: Khloris Biosciences, Mountain View, CA, United States
Michelle Li: Khloris Biosciences, Mountain View, CA, United States
Pratima Kundu: Khloris Biosciences, Mountain View, CA, United States
Nigel Kooreman: Khloris Biosciences, Mountain View, CA, United States
Stephen Wolpe: Khloris Biosciences, Mountain View, CA, United States
Lynne Bui: Khloris Biosciences, Mountain View, CA, United States
Carlos Obejero-Paz: Khloris Biosciences, Mountain View, CA, United States

DOI: https://doi.org/10.1136/jitc-2021-SITC2021.775
Journal volume & issue: Vol. 9, no. Suppl 2

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal